Trasylol Articles

Trasylol Articles:

The FDA Remains Broken, Trasylol, a Case In Point

Trasylol is a drug that promotes clotting and is given during heart by pass surgery. It is one of the new and expensive biotech drugs of Bayer. Patients generally don’t know they are getting it, and it significantly increases kidney failure and the likelihood they will die at a significantly increased rate in the next few years following surgery. You can imagine that giving a clotting drug to patients with clogged arteries may have some problems. There are other options that are inexpensive and don’t carry the risks.

Read More: Bayer, clogged arteries, kidneys, surgery, Trasylol

Amazingly, FDA has Bayer Pull Trasylol from the Market

Is the FDA really changing? Its hard to believe but the FDA finally acted in the best interests of consumers, shooting down a bio-tech drug that made Bayer millions and was at one time on the verge of becoming a blockbuster. I have openly criticized the FDA for some time on Trasylol, as it dragged its feet on this issue for almost two years.

Read More: Bayer, FDA, Trasylol

Congressman Calls for FDA Chief Resignation

In the face of mounting drug scandals and perjured congressional testimony, a key House Democrat, Rep. Bart Stupak (D-MI), told the Associated Press that FDA Commissioner Andrew von Eschenbach should step down. Stupak sites a “total lack of leadership” as it becomes plainly apparent that the FDA is unable to protect Americans from the dangers of drugs or ensure a safe food supply. The most troubling issue regarding FDA leadership is that many of these issues are due to gross negligence or taking the side of drug companies at the expense of human health.

Read More: Andrew von Eschenbach, antibiotics, Bayer, China, deaths, drug scandals, FDA, Heparin, Ketek, liver failure, Trasylol

China’s Ineptitude is Exposing FDA Negligence

The sparks flew on Capital Hill last week. During grilling of FDA executives Rep. John Dingell (D., Mich.), the chairman of the House Commerce and Energy Committee, said "Our citizens can no longer trust that their food, drugs or medical devices are safe when the FDA says they are."

Read More: China, Congress, FDA, Heparin, Trasylol